Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

[1]  A. J. van der Kooi,et al.  Troponin T and troponin I in carriers of Duchenne and Becker muscular dystrophy with cardiac involvement. , 2001, Clinical chemistry.

[2]  D. Kass,et al.  Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy , 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[3]  M. Grounds,et al.  Two-tiered hypotheses for Duchenne muscular dystrophy , 2008, Cellular and Molecular Life Sciences.

[4]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[5]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[6]  D. Allen,et al.  Stretch-induced membrane damage in muscle: comparison of wild-type and mdx mice. , 2010, Advances in experimental medicine and biology.

[7]  W. Wijns,et al.  Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study. , 2013, Journal of the American College of Cardiology.

[8]  G. Daley,et al.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.

[9]  K. McDonald,et al.  Eccentric contraction injury in dystrophic canine muscle. , 2002, Archives of physical medicine and rehabilitation.

[10]  H. Tse,et al.  Generation of induced pluripotent stem cells from urine. , 2011, Journal of the American Society of Nephrology : JASN.

[11]  Carissa Ritner,et al.  Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation , 2010, Journal of visualized experiments : JoVE.

[12]  Z. Bosnjak,et al.  Anesthetic-induced Preconditioning Delays Opening of Mitochondrial Permeability Transition Pore via Protein Kinase C-ϵ–mediated Pathway , 2009, Anesthesiology.

[13]  Christopher Baum,et al.  Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  J. De Pooter,et al.  Elevated troponin T levels in a female carrier of Duchenne muscular dystrophy with normal coronary angiogram: a case report and review of the literature , 2012, Acta cardiologica.

[15]  Dmitri B. Papkovsky,et al.  Live Cell Imaging , 2010, Methods in Molecular Biology.

[16]  Naofumi Ito,et al.  Reprogramming of human somatic cells by bacteria , 2015, Development, growth & differentiation.

[17]  K. Golka,et al.  Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system , 2000, Archives of Toxicology.

[18]  K. Davies,et al.  Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. , 2011, Human molecular genetics.

[19]  D. Duan,et al.  Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. , 2013, Human molecular genetics.

[20]  Anthony Atala,et al.  Urine derived cells are a potential source for urological tissue reconstruction. , 2008, The Journal of urology.

[21]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[22]  Bernard Dan,et al.  Pathophysiology of duchenne muscular dystrophy: current hypotheses. , 2007, Pediatric neurology.

[23]  A. Atala,et al.  736 URINE DERIVED STEM CELLS WITH HIGH TELOMERASE ACTIVITY FOR CELL BASED THERAPY IN UROLOGY , 2012 .

[24]  T. Omland.  Sensitive cardiac troponin assays: sense and sensibility. , 2012, European heart journal.

[25]  S. Oshima,et al.  Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure , 2012, Journal of internal medicine.

[26]  M. Phillips,et al.  Calcium antagonists for Duchenne muscular dystrophy. , 2008, The Cochrane database of systematic reviews.

[27]  K. McDonald,et al.  Skinned single fibers from normal and dystrophin‐deficient dogs incur comparable stretch‐induced force deficits , 2005, Muscle & nerve.

[28]  J. Kornegay,et al.  Myofiber Injury and Regeneration in a Canine Homologue of Duchenne Muscular Dystrophy , 2001, American journal of physical medicine & rehabilitation.

[29]  Zhaohui Ye,et al.  Generation of endoderm‐derived human induced pluripotent stem cells from primary hepatocytes , 2010, Hepatology.

[30]  J. Hell,et al.  Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits , 1993, The Journal of cell biology.

[31]  James M. Allen,et al.  Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  D. Deyle.  Generation of induced pluripotent stem cells. , 2015, Methods in molecular biology.

[33]  H. Tse,et al.  Generation of human induced pluripotent stem cells from urine samples , 2012, Nature Protocols.

[34]  J. Kornegay,et al.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.

[35]  Jack H. Ladenson,et al.  Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.

[36]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[37]  C. Ramaciotti,et al.  Myocardial Cell Damage in Duchenne Muscular Dystrophy , 2003, Pediatric Cardiology.

[38]  H. Vandenburgh,et al.  Hypotonicity stimulates translocation of ICln in neonatal rat cardiac myocytes , 1998, Pflügers Archiv.

[39]  A. Atala,et al.  Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. , 2011, Tissue engineering. Part A.

[40]  Hanns Lochmüller,et al.  Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations. , 2013, Stem cells and development.